Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision indicator updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:05:54.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3. No visible changes to study details, eligibility criteria, or locations.
    Difference
    0.1%
    Check dated 2026-03-06T18:31:17.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; this is a minor platform update with no changes to study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:20:41.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    - Revision: v3.4.1 added; Revision: v3.4.0 removed.
    Difference
    0.1%
    Check dated 2026-02-06T09:22:12.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added UI text for glossary toggles (Show glossary, Hide glossary) and new policy/version labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0); removed the prior wording (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-22T17:57:39.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:53.000Z thumbnail image

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.